Conference Quotables: 'Tempest in a Teapot'

George Church, a professor of genetics at Harvard Medical School, on the recent court decision that invalidated seven patents protecting Myriad Genetics' BRCA1 and BRCA2 breast and ovarian cancer predisposition tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.